nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aetiology of preterm labour: bacterial vaginosis
|
Guaschino, S |
|
2006 |
113 |
s3 |
p. 46-51 |
artikel |
2 |
A quality assessment tool to evaluate tocolytic studies
|
Lamont, RF |
|
2006 |
113 |
s3 |
p. 96-99 |
artikel |
3 |
Clinical practice evaluation of atosiban in preterm labour management in six European countries
|
Husslein, P |
|
2006 |
113 |
s3 |
p. 105-110 |
artikel |
4 |
Continuing challenges in treating preterm labour: preterm prelabour rupture of the membranes
|
Helmer, H |
|
2006 |
113 |
s3 |
p. 111-112 |
artikel |
5 |
Diagnosis of early preterm labour
|
Herbst, A |
|
2006 |
113 |
s3 |
p. 60-67 |
artikel |
6 |
Does assisted reproduction technology, per se, increase the risk of preterm birth?
|
Blickstein, I |
|
2006 |
113 |
s3 |
p. 68-71 |
artikel |
7 |
Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers
|
Kim, A |
|
2006 |
113 |
s3 |
p. 113-115 |
artikel |
8 |
EPICure: facts and figures: why preterm labour should be treated
|
Costeloe, K |
|
2006 |
113 |
s3 |
p. 10-12 |
artikel |
9 |
Management of the neonate at the limits of viability: the Dutch viewpoint
|
Verloove-Vanhorick, SP |
|
2006 |
113 |
s3 |
p. 13-16 |
artikel |
10 |
Mode of delivery in the early preterm infant (<28 weeks)
|
Drife, J |
|
2006 |
113 |
s3 |
p. 81-85 |
artikel |
11 |
‘Normal’ pregnancy with adverse events on initial tocolytic treatment
|
Dudenhausen, J |
|
2006 |
113 |
s3 |
p. 116-117 |
artikel |
12 |
Prematurity or immaturity?
|
Steer, PJ |
|
2006 |
113 |
s3 |
p. 136-138 |
artikel |
13 |
Preterm birth: the value of sonographic measurement of cervical length
|
Kagan, KO |
|
2006 |
113 |
s3 |
p. 52-56 |
artikel |
14 |
Regulatory and methodologic challenges to tocolytic development
|
Goodwin, TM |
|
2006 |
113 |
s3 |
p. 100-104 |
artikel |
15 |
Setting up a preterm prevention clinic: a practical guide
|
Lamont, RF |
|
2006 |
113 |
s3 |
p. 86-92 |
artikel |
16 |
Should every unit have a 24-hour transvaginal ultrasound available?
|
Robson, M |
|
2006 |
113 |
s3 |
p. 57-59 |
artikel |
17 |
The cost of preterm birth: the low cost versus high value of tocolysis
|
Gilbert, WM |
|
2006 |
113 |
s3 |
p. 4-9 |
artikel |
18 |
The epidemiology of preterm labour—why have advances not equated to reduced incidence?
|
Steer, PJ |
|
2006 |
113 |
s3 |
p. 1-3 |
artikel |
19 |
The preterm parturition syndrome
|
Romero, R |
|
2006 |
113 |
s3 |
p. 17-42 |
artikel |
20 |
The quality of randomised trials of tocolysis
|
Thornton, JG |
|
2006 |
113 |
s3 |
p. 93-95 |
artikel |
21 |
The role of inflammation in preterm birth—focus on periodontitis
|
Klebanoff, M |
|
2006 |
113 |
s3 |
p. 43-45 |
artikel |
22 |
The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome
|
Romero, R |
|
2006 |
113 |
s3 |
p. 118-135 |
artikel |
23 |
Use of tocolytics: what is the benefit of gaining even more time?
|
Jacquemyn, Y |
|
2006 |
113 |
s3 |
p. 78-80 |
artikel |
24 |
Use of tocolytics: what is the benefit of gaining 48 hours for the fetus?
|
Di Renzo, GC |
|
2006 |
113 |
s3 |
p. 72-77 |
artikel |